4.6 Article

Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study

Journal

PLOS ONE
Volume 15, Issue 7, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0235562

Keywords

-

Funding

  1. Mazandaran University of Medical Sciences, Sari, Iran

Ask authors/readers for more resources

Introduction The incidence rate of MS is a valuable indicator of the recent changes in the risk of this disease, and it is widely implicated for health planning purposes. Objectives This study aims to determine the MS incidence over the past eleven years in Mazandaran province and to compare it with the other parts of Iran and the world. Materials and methods This retrospective study is conducted in Mazandaran province by using registered data in the files of the patients with their consent. The yearly crude incidence rates, age, and sex-specific incidence rates and directly standardized incidence rates of this population are calculated, and the temporal changes in the incidence rates are analyzed. Results 662 (26%) male patients with the mean (SD) age of 32.6 (9.48) and 1884 (74%) female patients with the mean (SD) age of 31.9 (9.15) are studied. The direct standardized incidence rate of MS was 3.28 in 100.000 in 2008 and reached 4.17 in 100.000 in 2018, and this increase was significant (p<0.05). Also, the yearly prevalence of MS increased from 24.4 to 72.5 in this period. Conclusions The MS incidence has increased in Mazandaran. The potential role of some genetic or environmental factors needs further investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex

Zainab Bandalizadeh, Tahereh Shokohi, Hamid Badali, Mahdi Abastabar, Farhang Babamahmoudi, Lotfolah Davoodi, Masoud Mardani, Mostafa Javanian, Hamed Cheraghmakani, Ali Asghar Sepidgar, Parisa Badiee, Sadegh Khodavaisy, Setareh Agha Kuchak Afshari, Kazem Ahmadikia, Seyedmojtaba Seyedmousavi

JOURNAL OF MEDICAL MICROBIOLOGY (2020)

Article Clinical Neurology

Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018

Seyed Mohammad Baghbanian, Hamed Cheraghmakani, Reza HabibiSaravi, Arash Azar, Fariba Ghasemihamedani

BMC NEUROLOGY (2020)

Editorial Material Clinical Neurology

Interferon Beta-1a Cardiomyopathy in a Patient with Multiple Sclerosis: Case Report

H. Cheraghmakani, H. R. Samaee, M. Ghazaeian

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Neurosciences

Ischemic stroke associated with novel coronavirus 2019: a report of three cases

Athena Sharifi-Razavi, Narges Karimi, Ashraf Zarvani, Hamed Cheraghmakani, Seyyed Mohammad Baghbanian

Summary: This report describes three cases of ischemic stroke associated with COVID-19 infection, with severe symptoms and involvement of large cerebral arteries in all patients, suggesting a potential link between COVID-19 and ischemic stroke that requires further research.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2021)

Article Neurosciences

Resting-State Brain Network Deficits in Multiple Sclerosis Participants: Evidence from Electroencephalography and Graph Theoretical Analysis

Mojtaba Jouzizadeh, Amir Hossein Ghaderi, Hamed Cheraghmakani, Seyed Mohammad Baghbanian, Reza Khanbabaie

Summary: This study investigated the resting-state brain network impairments in patients with multiple sclerosis (MS) using EEG and graph theoretical analysis. The results showed significant differences in betweenness centrality (BC) and small-world propensity (SWP) in the alpha band between the MS group and the normal group, indicating disruptions in the brain network of MS patients at both local and global scales.

BRAIN CONNECTIVITY (2021)

Article Clinical Neurology

Ciprofloxacin for treatment of drug-resistant epilepsy

Hamed Cheraghmakani, Mohammad Sadegh Rezai, Reza Valadan, Golnar Rahimzadeh, Mona Moradi, Vahid Jahanfekr, Mahmood Moosazadeh, Nasim Tabrizi

Summary: The study revealed that short-term treatment with ciprofloxacin can significantly alter the gut microbiota pattern of patients and reduce seizure frequency, especially in patients with symptomatic generalized epilepsy.

EPILEPSY RESEARCH (2021)

Article Medicine, General & Internal

Reversible blindness after erroneous prescription of closantel: A case report

Hamed Cheraghmakani, Reza Jafari, Elahe Karimpour-Razkenari, Monireh Ghazaeian

Summary: A 20-year-old girl experienced vision loss due to closantel use, but improved vision was observed after treatment with plasma exchange and high-dose corticosteroid therapy. Early treatment may help reverse closantel toxicity.

CLINICAL CASE REPORTS (2021)

Review Public, Environmental & Occupational Health

Disaster and Multiple Sclerosis: A Systematic Review

Reza HabibiSaravi, Seyed Mohammad Baghbanian, Ramin Navaie, Nasrin Sayfouri, Hesam Seyedin, Farzad Gohardehi, Fariba Ghasemihamedani

Summary: This study reviews the existing research on disasters and disaster management planning for Multiple Sclerosis (MS) patients. The findings suggest a lack of proper planning to address the specific needs of MS patients in responding to disasters.

IRANIAN JOURNAL OF PUBLIC HEALTH (2022)

Review Cardiac & Cardiovascular Systems

Flood and hypertension: A systematic review

Reza Habibisaravi, Touraj Assadi, Gholam Gholami, Mehdi Hasani, Soheil Pourmand, Ramin Navaie, Fariba Ghasemihamedani

Summary: This study investigated the effects of floods on hypertension and found that floods have a significant impact on high blood pressure. Factors such as anxiety level, property loss, financial loss, physical activity, use of alcoholic beverages, interruption of medication, and medical cares were positively correlated with hypertension.

RESEARCH IN CARDIOVASCULAR MEDICINE (2022)

Article Medicine, General & Internal

Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study

Rozita Doosti, Abdorreza Naser Moghadasi, Amir Reza Azimi, Shahrokh Karbalai Saleh, Masoud Etemadifar, Vahid Shaygannejad, Fereshteh Ashtari, Mohammad Hossein Harirchian, Seyed Bahaadin Siroos, Hormoz Ayramloo, Nastaran Majdinasab, Seyyed Mohammad Masood Hojjati, Nabiollah Asghari, Seyed Mohammad Baghbanian, Hamed Cheraghmakani, Mahmoud Abedini, Behnaz Sedighi, Negar Mohseni Abbas Abadi, Maedeh Ghasemitabar, Sara Talebianpour, Tohid Babayi Daylari, Vahid Dana, Neda Ghaleh Noie, Mohammad Ali Sahraian

Summary: This study in Iranian MS patients evaluated the safety and efficacy of fingolideR 0.5 mg, finding that patients experienced a decrease in EDSS values during treatment, while the annualized relapse rate (ARR) and disease progression remained stable after 12 months of treatment.

CASPIAN JOURNAL OF INTERNAL MEDICINE (2021)

Meeting Abstract Clinical Neurology

Frequency of Transfusion in Multiple Sclerosis Patients

Seyed Mohammad Baghbanian, Hamed Cheraghmakani, Reza HabibiSaravi

MULTIPLE SCLEROSIS JOURNAL (2019)

Meeting Abstract Clinical Neurology

Frequency of Divorce in Patients with Multiple Sclerosis

Hamed Cheraghmakani, Seyed Mohammad Baghbanian, Reza Habibisaravi

MULTIPLE SCLEROSIS JOURNAL (2019)

No Data Available